Related references
Note: Only part of the references are listed.Enhancement of Drug Sensitivity by Knockdown of HIF-1α in Gastric Carcinoma Cells
Qun Zhao et al.
ONCOLOGY RESEARCH (2016)
Association of steroid and xenobiotic receptor (SXR) and multidrug resistance 1 (MDR1) gene expression with survival among patients with invasive bladder carcinoma
Jorge Rioja et al.
BJU INTERNATIONAL (2011)
Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells
Wataru Habano et al.
BMC CANCER (2011)
Differential expression of the nuclear receptors farnesoid X receptor (FXR) and pregnane X receptor (PXR) for grading dysplasia in patients with Barrett's oesophagus
Anouk van de Winkel et al.
HISTOPATHOLOGY (2011)
Pregnane X Receptor PXR Activates the GADD45β Gene, Eliciting the p38 MAPK Signal and Cell Migration
Susumu Kodama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Pregnane X receptor suppresses proliferation and tumourigenicity of colon cancer cells
N. Ouyang et al.
BRITISH JOURNAL OF CANCER (2010)
PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line
Stefan Harmsen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Bisphenol A and estradiol are equipotent in antagonizing cisplatin-induced cytotoxicity in breast cancer cells
Elizabeth W. LaPensee et al.
CANCER LETTERS (2010)
Steroid and xenobiotic receptor in human esophageal squamous cell carcinoma: A potent prognostic factor
Daisuke Takeyama et al.
CANCER SCIENCE (2010)
Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy
Elizabeth W. LaPensee et al.
ENDOCRINE-RELATED CANCER (2010)
Evaluation of Computational Docking to Identify Pregnane X Receptor Agonists in the ToxCast Database
Sandhya Kortagere et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2010)
Pregnane x Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation
Caroline Raynal et al.
MOLECULAR CANCER (2010)
Environmental causes of cancer: endocrine disruptors as carcinogens
Ana M. Soto et al.
NATURE REVIEWS ENDOCRINOLOGY (2010)
Steroid and Xenobiotic Receptor (SXR) as a possible prognostic marker in epithelial ovarian cancer
Xiaoni Yue et al.
PATHOLOGY INTERNATIONAL (2010)
Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
Regina Goetz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19)
Xinle Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The intraportal injection model: A practical animal model for hepatic metastases and tumor cell dissemination in human colon cancer
Andreas Thalheimer et al.
BMC CANCER (2009)
Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cells
Suman Verma et al.
BMC CANCER (2009)
Resistance to Chemotherapy Is Associated with Fibroblast Growth Factor Receptor 4 Up-Regulation
Andreas Roidl et al.
CLINICAL CANCER RESEARCH (2009)
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Evanthia Diamanti-Kandarakis et al.
ENDOCRINE REVIEWS (2009)
Association of Pregnane X Receptor with Multidrug Resistance-Related Protein 3 and its Role in Human Colon Cancer Chemoresistance
Heng Jiang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
The FGF family: biology, pathophysiology and therapy
Andrew Beenken et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Elucidating the 'Jekyll and Hyde' Nature of PXR: The Case for Discovering Antagonists or Allosteric Antagonists
Arunima Biswas et al.
PHARMACEUTICAL RESEARCH (2009)
Human pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alpha
Isabel Conde et al.
BMC CANCER (2008)
Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients
Shanaz H. Dairkee et al.
CANCER RESEARCH (2008)
Expanding the roles for pregnane X receptor in cancer: Proliferation and drug resistance in ovarian cancer
Divya Gupta et al.
CLINICAL CANCER RESEARCH (2008)
Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer
Danielle Meijer et al.
ENDOCRINE-RELATED CANCER (2008)
Lessons learned from a decade of clinical trials of high-dose chemotherapy in ovarian cancer
J. A. Ledermann
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
The antiapoptotic role of pregnane x receptor in human colon cancer cells
Jie Zhou et al.
MOLECULAR ENDOCRINOLOGY (2008)
The phytoestrogen Coumestrol is a naturally occurring antagonist of the human pregnane x receptor
Hongwei Wang et al.
MOLECULAR ENDOCRINOLOGY (2008)
Nuclear receptors of the enteric tract: guarding the frontier
Daniel R. Schmidt et al.
NUTRITION REVIEWS (2008)
Pregnane X receptor is essential for normal progression of liver regeneration
Guoli Dai et al.
HEPATOLOGY (2008)
Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models
Lr Desnoyers et al.
ONCOGENE (2008)
Human pregnane x receptor and resistance to chemotherapy in prostate cancer
Yakun Chen et al.
CANCER RESEARCH (2007)
Down-regulation of pregnane X receptor contributes to cell growth inhibition and apoptosis by anticancer agents in endometrial cancer cells
Hisashi Masuyama et al.
MOLECULAR PHARMACOLOGY (2007)
Lithocholic acid induction of the FGF19 promoter in intestinal cells is mediated by PXR
Wolfgang Wistuba et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-κB target gene expression
Yatrik M. Shah et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole
H. Huang et al.
ONCOGENE (2007)
CYP3A4 and pregnane X receptor humanized mice
Frank J. Gonzalez
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2007)
The endocrine disrupting chemical, diethylhexyl phthalate, activates MDR1 gene expression in human colon cancer LS174T cells
Akira Takeshita et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Multi-miRNA hairpin method that improves gene knockdown efficiency and provides linked multi-gene knockdown
Daqian Sun et al.
BIOTECHNIQUES (2006)
A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids
DM Shih et al.
JOURNAL OF LIPID RESEARCH (2006)
Opinion - Migrating cancer stem cells - an integrated concept of malignant tumour progression
T Brabletz et al.
NATURE REVIEWS CANCER (2005)
Activation of the steroid and xenobiotic receptor (Human pregnane X receptor) by nontaxane microtubule-stabilizing agents
S Mani et al.
CLINICAL CANCER RESEARCH (2005)
Endocrine disruptors induce cytochrome P450 by affecting transcriptional regulation via pregnane X receptor
E Mikamo et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2003)
The nuclear pregnane X receptor: A key regulator of xenobiotic metabolism
SA Kliewer et al.
ENDOCRINE REVIEWS (2002)
Nuclear receptors and lipid physiology: Opening the X-files
A Chawla et al.
SCIENCE (2001)
The human nuclear xenobiotic receptor PXR: Structural determinants of directed promiscuity
RE Watkins et al.
SCIENCE (2001)
Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin
A Geick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands
LB Moore et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
